EDENRED EO 2/ FR0010908533 /
30/05/2024 9:57:45 | Diferencia -0.700 | Volumen | Bid9:57:45 | Ask9:57:45 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
42.350EUR | -1.63% | - Volumen de negocios: - |
42.350Volumen de oferta: - | 42.360Tamaño/ Volumen/ Formato de Ask: - | 10.49 mil millonesEUR | 2.61% | 39.36 |
GlobeNewswire
9:42
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
9:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
9:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
9:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página